News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Private Equity

Permira to take UK-listed Ergomed private in £703m deal

The directors of Ergomed, who have been advised by Jefferies and Numis, said they considered the terms of the cash offer to be fair and reasonable

AIM-listed Ergomed provides services to the pharmaceutical industry and the development of new drugs across 100 countries
AIM-listed Ergomed provides services to the pharmaceutical industry and the development of new drugs across 100 countries Photo: Getty Images/Westend61

Permira has kicked off the week with a public-to-private takeover, agreeing to buy British biopharmaceutical services company Ergomed for £703.1m.

The European private equity house said on 4 September that the cash offer of 1,350p per share marks a 28% premium to Ergomed’s last closing price.

WSJ Logo